Pasar al contenido principal
Un sitio oficial del Gobierno de Estados Unidos
English
Enviar por correo electrónico

Consejo editorial del PDQ® sobre la genética del cáncer

Este consejo editorial está integrado por expertos en el ámbito de la genética, oncología clínica, epidemiología, psicología y las ciencias sociales. El consejo editorial se reúne tres veces al año y su propósito principal es producir y actualizar resúmenes de información sobre el cáncer que tratan sobre el campo de la genética del cáncer.

  • Tuya Pal, M.D., Presidenta
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee
  • Matthew B. Yurgelun, M.D., Vicepresidente
    Dana-Farber Cancer Institute
    Boston, Massachusetts
  • Doreen Agnese, M.D.
    The Ohio State University
    Columbus, Ohio
  • Melyssa Aronson, M.S., C.G.C., C.C.G.C.
    Sinai Health System
    Toronto, Ontario, Canadá
  • Erica Blouch, M.S., C.G.C.
    Mass General Cancer Center
    Boston, Massachusetts
  • Kathleen A. Calzone, Ph.D., R.N., A.P.N.G., F.A.A.N.
    National Cancer Institute
    Bethesda, Maryland
  • Ilana Cass, M.D.
    Dartmouth-Hitchcock Medical Center
    Lebanon, Nuevo Hampshire
  • Lee-may Chen, M.D.
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California
  • Julia Cooper, M.S., C.G.C.
    The Ohio State University
    Columbus, Ohio
  • Mary B. Daly, M.D., Ph.D.
    Fox Chase Cancer Center
    Filadelfia, Pensilvania
  • Courtney DiNardo, M.D., M.S.C.
    University of Texas, M.D. Anderson Cancer Center
    Houston, Texas
  • Grace-Ann Fasaye, Sc.M., C.G.C.
    National Cancer Institute
    Bethesda, Maryland
  • Zachariah Foda, M.D., Ph.D.
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
  • Megan Frone, M.S., C.G.C.
    National Cancer Institute
    Rockville, Maryland
  • Katharine Germansky, M.D.
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts
  • Veda N. Giri, M.D.
    Yale University
    New Haven, Connecticut
  • Jessica Hatton, M.S., C.G.C.
    National Cancer Institute
    Rockville, Maryland
  • Joanne Jeter, M.D., M.S.
    City of Hope
    Duarte, California
  • Joanne Kotsopoulos, Ph.D.
    University of Toronto
    y
    Women’s College Hospital
    Toronto, Ontario, Canadá
  • Alexandra Lebensohn, M.S., C.G.C.
    National Cancer Institute
    Bethesda, Maryland
  • David Liska, M.D., M.A.
    Cleveland Clinic
    Cleveland, Ohio
  • Gautam Mankaney, M.D.
    Virginia Mason Franciscan Health
    Seattle, Washington
  • Kelly C. Nelson, M.D.
    University of Texas, M.D. Anderson Cancer Center
    Houston, Texas
  • Suzanne O’Neill, Ph.D.
    Georgetown University
    Washington, Distrito de Columbia
  • Nancy D. Perrier, M.D., F.A.C.S.
    University of Texas, M.D. Anderson Cancer Center
    Houston, Texas
  • Mark Pomerantz, M.D.
    Dana-Farber Cancer Institute
    Boston, Massachusetts
  • John M. Quillin, Ph.D., M.S., M.P.H., C.G.C.
    Virginia Commonwealth University
    Richmond, Virginia
  • Padma Sheila Rajagopal, M.D., M.P.H., M.Sc.
    National Cancer Institute
    Bethesda, Maryland
  • Charité Ricker, M.S., C.G.C.
    University of Southern California
    Los Ángeles, California
  • Sarah Scollon, M.S., C.G.C.
    Baylor College of Medicine
    y
    Texas Children’s Hospital
    Houston, Texas
  • Brian M. Shuch, M.D.
    UCLA Health
    Los Ángeles, California
  • Ramaprasad Srinivasan, M.D., Ph.D.
    National Cancer Institute
    Bethesda, Maryland
  • Douglas Stewart, M.D.
    National Cancer Institute
    Rockville, Maryland
  • Amanda E. Toland, Ph.D., F.A.C.M.G.
    The Ohio State University
    Columbus, Ohio
  • Catharine Wang, Ph.D., M.Sc.
    Boston University School of Public Health
    Boston, Massachusetts
  • Marcin Wlodarski, M.D., Ph.D.
    St. Jude Children's Research Hospital
    Memphis, Tennessee
  • Kevin Zbuk, M.D., F.R.C.P.C.
    Margaret and Charles Juravinski Cancer Centre
    Hamilton, Ontario, Canadá
  • Actualización: